Key result
DeltaK1479 mutation positively shifts half-activation potential, suggesting conduction slowing alone can produce the Brugada phenotype.
Why the study?
Some mutations of the sodium channel gene Na(V1.5) cause combinations of Brugada syndrome and progressive cardiac conduction system disease, but the mechanisms linking conduction slowing to the Brugada phenotype are unclear.
Absolute Event Rate: -24.5% vs -36.8%
Experimental and theoretical modeling suggests that conduction slowing alone, resulting from sodium channel loss-of-function mutations, is sufficient to produce the Brugada syndrome phenotype without requiring marked repolarization heterogeneity.
No takes yet. Share an insight, caveat, or question.
Conduction slowing alone may suffice for Brugada phenotype in models; leaves open dominant mechanism and need for human validation.
Zhang et al. (2006) studied Brugada syndrome and progressive cardiac conduction system disease. DeltaK1479 mutation in Na(V1.5) vs. Wild-type sodium channel was evaluated on Potential of half-activation (V(1/2m)). The DeltaK1479 mutation shifts the potential of half-activation to more positive potentials (-24.5 mV vs -36.8 mV for wild-type), suggesting conduction slowing alone can produce the Brugada phenotype.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: